相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Progression of acromegalic arthropathy in long-term controlled acromegaly patients: 9 years of longitudinal follow-up
Iris C. M. Pelsma et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
A Pituitary Society update to acromegaly management guidelines
Maria Fleseriu et al.
PITUITARY (2021)
Acromegaly in remission: a view from the partner
Rachel Fourneaux et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2021)
Transition of young adults with endocrine and metabolic diseases: the 'TRANSEND' cohort
Enora Le Roux et al.
ENDOCRINE CONNECTIONS (2021)
Global epidemiology of acromegaly : a systematic review and meta-analysis
Salvatore Crisafulli et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2021)
Pegvisomant in combination or pegvisomant alone after failure of somatostatin analogs in acromegaly patients: an observational French ACROSTUDY cohort study
Emmanuelle Kuhn et al.
ENDOCRINE (2021)
Is MRI follow-up relevant in patients with GH-secreting pituitary adenomas primarily treated and responsive to long-acting somatostatin analogues (SMSa)?
Naia Grandgeorge et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2020)
A Consensus on the Diagnosis and Treatment of Acromegaly Comorbidities: An Update
Andrea Giustina et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
The Course of Obstructive Sleep Apnea Syndrome in Patients With Acromegaly During Treatment
Thalijn L. C. Wolters et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Obstructive Sleep Apnea in Acromegaly and the Effect of Treatment: A Systematic Review and Meta-Analysis
Matteo Parolin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Biliary Stone Disease in Patients with Neuroendocrine Tumors Treated with Somatostatin Analogs: A Multicenter Study
Nicole Brighi et al.
ONCOLOGIST (2020)
Hormone-related diseases and prostate cancer: An English national record linkage study
Eleanor L. Watts et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Frequency and Incidence of Carney Complex Manifestations: A Prospective Multicenter Study With a Three-Year Follow-Up
Stephanie Espiard et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Semen quality in hypogonadal acromegalic patients
Mikkel Andreassen et al.
PITUITARY (2020)
Acromegaly is associated with vertebral deformations but not vertebral fractures: Results of a cross-sectional monocentric study
Charlotte Plard et al.
JOINT BONE SPINE (2020)
Assessment of oro-dental manifestations in a series of acromegalic patients, the AcroDent study
Sylvain Roumeau et al.
ENDOCRINE CONNECTIONS (2020)
Evaluation of an individualized education program in pituitary diseases: a pilot study
F. Albarel et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2020)
Daily life, needs and expectations of patients with acromegaly in France: An on-line survey
Frederique Albarel et al.
ANNALES D ENDOCRINOLOGIE (2019)
Systemic Complications of Acromegaly and the Impact of the Current Treatment Landscape: An Update
Monica R. Gadelha et al.
ENDOCRINE REVIEWS (2019)
National acromegaly registries
Luigi Maione et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Acromegaly
Annamaria Colao et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
Bone disorders associated with acromegaly: mechanisms and treatment
Gherardo Mazziotti et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2019)
Modern neuro-ophthalmological evaluation of patients with pituitary disorders
Anne-Laure Vie et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Patients' perspectives on acromegaly diagnostic delay: a qualitative study
Jordan Sibeoni et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2019)
Pasireotide and Pegvisomant Combination Treatment in Acromegaly Resistant to Second-Line Therapies: A Longitudinal Study
Sabrina Chiloiro et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Emerging and Novel Treatments for Pituitary Tumors
Mirela Diana Ilie et al.
JOURNAL OF CLINICAL MEDICINE (2019)
A standardised diagnostic approach to pituitary neuroendocrine tumours (PitNETs): a European Pituitary Pathology Group (EPPG) proposal
C. Villa et al.
VIRCHOWS ARCHIV (2019)
The Clinicopathological Spectrum of Acromegaly
Amit Akirov et al.
JOURNAL OF CLINICAL MEDICINE (2019)
How to Position Pasireotide LAR Treatment in Acromegaly
Eva C. Coopmans et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
An update on clinical care for pregnant women with acromegaly
Philippe Chanson et al.
EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM (2019)
Effectiveness and safety of pegvisomant: a systematic review and meta-analysis of observational longitudinal studies
Leticia P. Leonart et al.
ENDOCRINE (2019)
Hepatic steatosis in patients with acromegaly
Andreani Koutsou-Tassopoulou et al.
ENDOCRINOLOGY DIABETES & METABOLISM (2019)
Diabetes in patients with acromegaly treated with pegvisomant: observations from acrostudy
Thierry Brue et al.
ENDOCRINE (2019)
European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas
Gerald Raverot et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2018)
Guidelines versus real life practice: the case of colonoscopy in acromegaly
M. Parolin et al.
PITUITARY (2018)
Growth hormone-producing pituitary adenomas in childhood and young adulthood: clinical features and outcomes
Yuichi Nagata et al.
PITUITARY (2018)
Outcome of pregnancies in a large cohort of women with acromegaly
R. S. Jallad et al.
CLINICAL ENDOCRINOLOGY (2018)
A randomised, open-label, parallel group phase 2 study of antisense oligonucleotide therapy in acromegaly
Peter J. Trainer et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2018)
Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016
Ann McCormack et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2018)
Cancer Incidence in Patients With Acromegaly: A Cohort Study and Meta-Analysis of the Literature
Jakob Dal et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Radiotherapy in acromegaly: Long-term brain parenchymal and vascular magnetic resonance changes
Laura Milanese et al.
JOURNAL OF NEURORADIOLOGY (2018)
Pediatric Pituitary Adenoma: Case Series, Review of the Literature, and a Skull Base Treatment Paradigm
Avital Perry et al.
JOURNAL OF NEUROLOGICAL SURGERY PART B-SKULL BASE (2018)
Diabetes Secondary to Acromegaly: Physiopathology, Clinical Features and Effects of Treatment
Francesco Ferrau et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
A Consensus Statement on acromegaly therapeutic outcomes
Shlomo Melmed et al.
NATURE REVIEWS ENDOCRINOLOGY (2018)
Long-term treatment with pegvisomant: observations from 2090 acromegaly patients in ACROSTUDY
Michael Buchfelder et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2018)
The causes and consequences of pituitary gigantism
Albert Beckers et al.
NATURE REVIEWS ENDOCRINOLOGY (2018)
Pre-surgical medical treatment, a major prognostic factor for long-term remission in acromegaly
F. Albarel et al.
PITUITARY (2018)
Oro-dental pathologies in acromegaly
Ilonka Kreitschmann-Andermahr et al.
ENDOCRINE (2018)
Long-Term Remission of Acromegaly after Octreotide Withdrawal Is an Uncommon and Frequently Unsustainable Event
Alessandra Casagrande et al.
NEUROENDOCRINOLOGY (2017)
Acromegaly: clinical features at diagnosis
Lucio Vilar et al.
PITUITARY (2017)
Epidemiology of acromegaly: review of population studies
Aikaterini Lavrentaki et al.
PITUITARY (2017)
Risk of malignant neoplasms in acromegaly: a case-control study
K. Wolinski et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2017)
Acromegaly at diagnosis in 3173 patients from the Liege Acromegaly Survey (LAS) Database
Patrick Petrossians et al.
ENDOCRINE-RELATED CANCER (2017)
Enhanced self-efficacy after a selfmanagement programme in pituitary disease: a randomized controlled trial
Cornelie D. Andela et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2017)
Acromegaly and pregnancy: a contemporary review
Julio Abucham et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2017)
Changes in the management and comorbidities of acromegaly over three decades: the French Acromegaly Registry
Luigi Maione et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2017)
Surgical debulking of pituitary adenomas improves responsiveness to octreotide lar in the treatment of acromegaly
Rudolf Fahlbusch et al.
PITUITARY (2017)
Incidence of myocardial infarction and stroke in acromegaly patients: results from the German Acromegaly Registry
Christof Schoefl et al.
PITUITARY (2017)
Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): A Pituitary Society Statement
Felipe F. Casanueva et al.
PITUITARY (2017)
Secondary Intracranial Tumors Following Radiotherapy for Pituitary Adenomas: A Systematic Review
Ryuya Yamanaka et al.
CANCERS (2017)
Effects of anti-somatostatin agents on glucose metabolism
B. Verges
DIABETES & METABOLISM (2017)
Growth hormone excess in children with neurofibromatosis type-1 and optic glioma
Paola Cambiaso et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2017)
Impaired quality of life in patients with treated acromegaly despite long-term biochemically stable disease: Results from a 5-years prospective study
Nikolaos Kyriakakis et al.
CLINICAL ENDOCRINOLOGY (2017)
Morphometric changes correlate with poor psychological outcomes in patients with acromegaly
Syed Ali Imran et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)
Surgical treatment of acromegaly according to the 2010 remission criteria: systematic review and meta-analysis
Daniele Starnoni et al.
ACTA NEUROCHIRURGICA (2016)
T2-weighted MRI signal predicts hormone and tumor responses to somatostatin analogs in acromegaly
Iulia Potorac et al.
ENDOCRINE-RELATED CANCER (2016)
Acromegaly and cancer: an old debate revisited
Cesar Luiz Boguszewski et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)
Acromegaly in sleep apnoea patients: a large observational study of 755 patients
Louis-Marie Galerneau et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
Reference Values for IGF-I Serum Concentrations: Comparison of Six Immunoassays
Philippe Chanson et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline
Maria Fleseriu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Micromegaly: an update on the prevalence of acromegaly with apparently normal GH secretion in the modern era
Laura B. Butz et al.
PITUITARY (2016)
Pegvisomant treatment in patients with acromegaly in clinical practice: The French ACROSTUDY
Philippe Chanson et al.
ANNALES D ENDOCRINOLOGIE (2015)
Clinical and genetic characterization of pituitary gigantism: an international collaborative study in 208 patients
Liliya Rostomyan et al.
ENDOCRINE-RELATED CANCER (2015)
Cabergoline Use for Pituitary Tumors and Valvular Disorders
Renata S. Auriemma et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2015)
Safety and Efficacy of Oral Octreotide in Acromegaly: Results of a Multicenter Phase III Trial
Shlomo Melmed et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Low Frequency of Cardiomyopathy Using Cardiac Magnetic Resonance Imaging in an Acromegaly Contemporary Cohort
Cintia Marques dos Santos Silva et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Clomiphene Citrate for Treatment of Acromegaly Not Controlled by Conventional Therapies
Felipe H. Duarte et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Bone Turnover, Bone Mineral Density, and Fracture Risk in Acromegaly: A Meta-Analysis
Gherardo Mazziotti et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Surgery induced hypopituitarism in acromegalic patients: a systematic review and meta-analysis of the results
Pedro Carvalho et al.
PITUITARY (2015)
Need for improved monitoring in patients with acromegaly
Julie M. Silverstein
ENDOCRINE CONNECTIONS (2015)
The role of colonoscopic screening in acromegaly revisited: review of current literature and practice guidelines
K. Lois et al.
PITUITARY (2015)
Should all patients with acromegaly receive somatostatin analogue therapy before surgery and, if so, for how long?
Jubbin J. Jacob et al.
CLINICAL ENDOCRINOLOGY (2014)
Growth Hormone, Insulin-Like Growth Factor-1, and the Kidney: Pathophysiological and Clinical Implications
Peter Kamenicky et al.
ENDOCRINE REVIEWS (2014)
Patients lost to follow-up in acromegaly: results of the ACROSPECT study
B. Delemer et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2014)
Surgical Interventions and Medical Treatments in Treatment-Naive Patients With Acromegaly: Systematic Review and Meta-Analysis
Abd Moain Abu Dabrh et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Acromegaly and McCune-Albright Syndrome
Sylvie Salenave et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Acromegaly: An Endocrine Society Clinical Practice Guideline
Laurence Katznelson et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Pasireotide Versus Octreotide in Acromegaly: A Head-to-Head Superiority Study
A. Colao et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
EXPERT CONSENSUS DOCUMENT A consensus on the medical treatment of acromegaly
Andrea Giustina et al.
NATURE REVIEWS ENDOCRINOLOGY (2014)
Gigantism and Acromegaly Due to Xq26 Microduplications and GPR101 Mutation
G. Trivellin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Prevalence and risk factors of impaired glucose tolerance and diabetes mellitus at diagnosis of acromegaly: a study in 148 patients
Orsalia Alexopoulou et al.
PITUITARY (2014)
Risk of Thyroid Nodular Disease and Thyroid Cancer in Patients with Acromegaly - Meta-Analysis and Systematic Review
Kosma Wolinski et al.
PLOS ONE (2014)
Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial
Monica R. Gadelha et al.
LANCET DIABETES & ENDOCRINOLOGY (2014)
A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case-control study of 410 patients with 8 years post-operative follow-up
Jacqueline Trouillas et al.
ACTA NEUROPATHOLOGICA (2013)
Efficacy of combined octreotide and cabergoline treatment in patients with acromegaly: a retrospective clinical study and review of the literature
Kentaro Suda et al.
ENDOCRINE JOURNAL (2013)
Familial Isolated Pituitary Adenomas (FIPA) and the Pituitary Adenoma Predisposition due to Mutations in the Aryl Hydrocarbon Receptor Interacting Protein (AIP) Gene
Albert Beckers et al.
ENDOCRINE REVIEWS (2013)
Genetic analysis in young patients with sporadic pituitary macroadenomas: besides AIP don't forget MEN1 genetic analysis
Thomas Cuny et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2013)
The Metabolic Profile in Active Acromegaly is Gender-Specific
A. Ciresi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Place of Preoperative Treatment of Acromegaly with Somatostatin Analog on Surgical Outcome: A Systematic Review and Meta-Analysis
Francisco Pita-Gutierrez et al.
PLOS ONE (2013)
Acromegaly induced by ectopic secretion of GHRH: A review 30 years after GHRH discovery
Francoise Borson-Chazot et al.
ANNALES D ENDOCRINOLOGIE (2012)
Clinical Characteristics and Outcome of Acromegaly Induced by Ectopic Secretion of Growth Hormone-Releasing Hormone (GHRH): A French Nationwide Series of 21 Cases
Laetitia Garby et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
No Evidence of a Detrimental Effect of Cabergoline Therapy on Cardiac Valves in Patients with Acromegaly
Luigi Maione et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Germline AIP Mutations in Apparently Sporadic Pituitary Adenomas: Prevalence in a Prospective Single-Center Cohort of 443 Patients
Laure Cazabat et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)
Rajesh V. Thakker et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Prognostic factors of visual field improvement after trans-sphenoidal approach for pituitary macroadenomas: review of the literature and analysis by quantitative method
Lina Raffaella Barzaghi et al.
NEUROSURGICAL REVIEW (2012)
Clinical factors involved in the recurrence of pituitary adenomas after surgical remission: a structured review and meta-analysis
Ferdinand Roelfsema et al.
PITUITARY (2012)
Clinical Features and Treatment of Pediatric Somatotropinoma: Case Study of an Aggressive Tumor due to a New AIP Mutation and Extensive Literature Review
Claire Personnier et al.
HORMONE RESEARCH IN PAEDIATRICS (2011)
Place of Cabergoline in Acromegaly: A Meta-Analysis
Laure Sandret et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Acromegaly Is Associated with an Increased Prevalence of Colonic Diverticula: A Case-Control Study
M. J. E. Wassenaar et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Clinical Characteristics and Therapeutic Responses in Patients with Germ-Line AIP Mutations and Pituitary Adenomas: An International Collaborative Study
Adrian F. Daly et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Role of stereotactic radiosurgery in the management of pituitary adenomas
Frederic Castinetti et al.
NATURE REVIEWS ENDOCRINOLOGY (2010)
Predicting Visual Outcome After Treatment of Pituitary Adenomas With Optical Coherence Tomography
Maud Jacob et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2009)
French consensus on the management of acromegaly
P. Chanson et al.
ANNALES D ENDOCRINOLOGIE (2009)
A randomized, controlled, multicentre trial comparing pegvisomant alone with combination therapy of pegvisomant and long-acting octreotide in patients with acromegaly
Peter J. Trainer et al.
CLINICAL ENDOCRINOLOGY (2009)
Monitoring of acromegaly: what should be performed when GH and IGF-1 levels are discrepant?
Pamela U. Freda
CLINICAL ENDOCRINOLOGY (2009)
CNS complications of radiotherapy and chemotherapy
Carole Soussain et al.
LANCET (2009)
Modern techniques for pituitary radiotherapy
G. Minniti et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2009)
Sleep apnoea syndrome is highly prevalent in acromegaly and only partially reversible after biochemical control of the disease
Maria Vittoria Davi et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
Treatment of pituitary gigantism with the growth hormone receptor antagonist pegvisomant
Naila Goldenberg et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Long-term efficacy and safety of combined treatment of somatostatin analogs and Pegvisomant in acromegaly
Sebastian J. C. M. M. Neggers et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Treatment of acromegaly: is there still a place for radiotherapy?
Raquel S. Jallad et al.
PITUITARY (2007)
Gamma knife radiosurgery for acromegaly -: long-term experience
J Jezková et al.
CLINICAL ENDOCRINOLOGY (2006)
Elevated transaminases during medical treatment of acromegaly: a review of the German pegvisomant surveillance experience and a report of a patient with histologically proven chronic mild active hepatitis
H Biering et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2006)
The long-term efficacy of conventional radiotherapy in patients with GH-secreting pituitary adenomas
G Minniti et al.
CLINICAL ENDOCRINOLOGY (2005)
Is there an association between acromegaly and thyroid carcinoma? A critical review of the literature
G Siegel et al.
ENDOCRINE RESEARCH (2005)
Consensus statement on the management of the GH-treated adolescent in the transition to adult care
PE Clayton et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2005)
Gross total resection or debulking of pituitary adenomas improves hormonal control of acromegaly by somatostatin analogs
P Petrossians et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2005)
Long-term outcome of patients with acromegaly and congestive heart failure
H Bihan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant
PJ Trainer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
